| Title |
Nanopharmaceuticals (part 1): products on the market
|
|---|---|
| Published in |
International Journal of Nanomedicine, September 2014
|
| DOI | 10.2147/ijn.s46900 |
| Pubmed ID | |
| Authors |
Volkmar Weissig, Tracy K Pettinger, Nicole Murdock |
| Abstract |
In 2000, the National Institute of Health launched the National Nanotechnology Initiative to support, coordinate, and advance research and development of nanoscale projects. The impact of this new program on health-science related research and development became quickly visible. Broad governmental financial support advanced the start of new, and the deepening of already existing, interdisciplinary research. The anticipated merger of nanoscience with medicine quickly instigated the conceptualization of nanomedicine. The adoption of nanoscience terminology by pharmaceutical scientists resulted in the advent of nanopharmaceuticals. The term "nano" became tantamount to "cutting-edge" and was quickly embraced by the pharmaceutical science community. Colloidal drug delivery systems reemerged as nanodrug delivery systems; colloidal gold became a suspension of nano gold particles. In this review, we first review nanoscience related definitions applied to pharmaceuticals, we then discuss all 43 currently approved drug formulations which are publicized as nanopharmaceuticals, and finally we analyze clinical aspects of selected drug formulations. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 40% |
| Netherlands | 1 | 20% |
| Spain | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 60% |
| Science communicators (journalists, bloggers, editors) | 1 | 20% |
| Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 720 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | <1% |
| Colombia | 1 | <1% |
| Germany | 1 | <1% |
| Canada | 1 | <1% |
| Brazil | 1 | <1% |
| United States | 1 | <1% |
| Poland | 1 | <1% |
| Unknown | 709 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 141 | 20% |
| Student > Master | 106 | 15% |
| Student > Bachelor | 83 | 12% |
| Researcher | 75 | 10% |
| Student > Doctoral Student | 43 | 6% |
| Other | 93 | 13% |
| Unknown | 179 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 162 | 23% |
| Chemistry | 81 | 11% |
| Agricultural and Biological Sciences | 60 | 8% |
| Biochemistry, Genetics and Molecular Biology | 59 | 8% |
| Medicine and Dentistry | 41 | 6% |
| Other | 87 | 12% |
| Unknown | 230 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2023.
All research outputs
#5,187,758
of 25,371,288 outputs
Outputs from International Journal of Nanomedicine
#471
of 4,121 outputs
Outputs of similar age
#49,900
of 248,664 outputs
Outputs of similar age from International Journal of Nanomedicine
#9
of 52 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,121 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,664 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.